Parent Drug Name | Name of Impurity | Catalogue No. | |
---|---|---|---|
Dantrolene | Dantrolene Related Compound A | VE006881 | View CAS 301359-05-7 |
Dantrolene | Dantrolene Related Compound B | VE006882 | View CAS 57268-33-4 |
Parent Drug Name | Name of Impurity | Catalogue No. | |
---|---|---|---|
Dantrolene | Dantrolene Related Compound A | VE006881 | View CAS 301359-05-7 |
Dantrolene | Dantrolene Related Compound B | VE006882 | View CAS 57268-33-4 |
Catalogue No. | VE006881 |
CAS No. | 301359-05-7 |
Molecular Formula | C22H14N4O6 |
Molecular Weight | 430.38 |
Parent drug | Dantrolene |
IUPAC Name | 1, 2-Bis{[5-(4-nitrophenyl)furan-2-yl]methylene}hydrazine |
Synonyms | N/A |
References | “Development and Application of a Validated Stability-Indicating Ultra-Performance Liquid Chromatography (UPLC) Method for the Determination of Dantrolene and Its Related Impurities.” Clinical Research and Regulatory Affairs, 2021, http://www.tandfonline.com/doi/abs/10.3109/10601331003623309.?Pinder, R. M., et al. “Dantrolene Sodium.” Drugs, vol. 13, no. 1, Jan. 1977, pp. 3–23, https://doi.org/10.2165/00003495-197713010-00002.? |
Status | In-stock |
ListName | Dantrolene Related Compound A |
Exclusively Supplied by Veeprho | Exclusively Supplied by Veeprho |
"*" indicates required fields